HOME >> MEDICINE >> NEWS
Joint statement on Savvy Phase 3 trial in Ghana to test the effectiveness of Savvy Gel in preventing HIV

cially the volunteers who have helped by their participation in this study.

Contraception trials of Savvy being conducted by other organizations in the United States with the support of the National Institutes of Health will continue as planned. Enrollment is continuing in the comparative contraception study at numerous sites in the U.S., and planning is underway for a second study for contraception, also in the U.S. Additional studies to examine Savvy's effectiveness against other sexually transmitted infections, including herpes, are planned in the near future.

FHI looks forward to continuing to work with partners on studies of Savvy and other microbicides with the potential to help prevent HIV.

Microbicide trials are critical to identifying new HIV prevention tools to reduce the number of individuals who become infected with HIV worldwide. Heterosexual contact accounts for more than 70 percent of all HIV infections worldwide. Correct and consistent use of male condoms has been shown to prevent HIV infection, but women are often unable to negotiate condom use with their male partners. This study is important because a woman-controlled method, such as a topical gel, would be an important addition to current preventive methods.


'"/>

Contact: Beth Robinson
media@fhi.org
919-405-1461
Rational PR
9-Nov-2005


Page: 1 2 3

Related medicine news :

1. Joint Principles of PC-MH released by organizations representing more than 300,000 physicians
2. AHA statement recommends doctors change approach
3. CHPA statement regarding Monitoring the Future findings on cough medicine abuse
4. International AIDS Vaccine Initiative statement on male circumcision
5. AASM position statement: Treating insomnia with over-the-counter sleep aids, herbal supplements
6. American Thoracic Society publishes new statement on hepatotoxicity of antituberculosis therapy
7. NHLBI and NIH statements on totally implanted permanent artificial heart
8. ESC statement on the CHARISMA trial on Clopidogrel (Plavix)
9. ESC issues policy statement on reperfusion therapy
10. American Dietetic Association statement on new MyPyramid
11. GSK announces launch of largest ever Phase III trial in lung cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... ... 11, 2019 , ... Executives at health systems and hospitals across America are ... over the past several years has been intense. For professionals and organizations that struggle ... America will depend largely on how these executives respond. Will they have the tools ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... facing the ever-changing corporate landscape, Mediaplanet today announces the launch of its ... topics ranging from the importance of candid one-on-one conversations, ideas for improving ...
(Date:9/9/2019)... ... September 09, 2019 , ... ... Dentistry in Cornelius, NC, now welcome individuals with tooth loss in Davidson, NC ... with patients who have single or multiple missing teeth and want the advantages ...
(Date:9/9/2019)... ... September 09, 2019 , ... On September 6, 2019, ... on a diabetes-language movement (#LanguageMatters) to include oral and written language. The organization ... stigma, respectful and inclusive, empowering, and person-centered (to include care that is respectful ...
(Date:9/8/2019)... ... 2019 , ... The Southern Illinois University Edwardsville School of ... reached an all-time high with 1,778 students. , The SON’s enrollment features ... students. The total does not include an additional 30 undeclared graduate students, who ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... 14, 2019 , ... On September 11, 2019, after a ... in Middlesex County found Johnson & Johnson liable for causing the Plaintiffs’ cancers. ... by asbestos-containing J&J talc products. , A unanimous jury found that ...
(Date:9/12/2019)... ... September 12, 2019 , ... iPatientCare, a ... practice management, and patient engagement solutions, announced today the participation of Amazon ... (NUCON) 2019 . The annual conference features informative sessions about upcoming enhancements, ...
(Date:9/11/2019)... ... September 12, 2019 , ... Understanding the Drug ... FDAnews Webinar, Thursday, Sept. 26, 2019, 1:30-3:00 p.m. EDT, https://www.fdanews.com/understanding-the-dscsa , ... Is the company clear on nuances of the guidelines regulating the drug supply ...
Breaking Medicine Technology:
Cached News: